Literature DB >> 16231040

Variants in Apaf-1 segregating with major depression promote apoptosome function.

J Harlan1, Y Chen, E Gubbins, R Mueller, J-M Roch, K Walter, M Lake, T Olsen, P Metzger, S Dorwin, U Ladror, D A Egan, J Severin, R W Johnson, T F Holzman, K Voelp, C Davenport, A Beck, J Potter, M Gopalakrishnan, A Hahn, B B Spear, D N Halbert, J P Sullivan, V Abkevich, C D Neff, M H Skolnick, D Shattuck, D A Katz.   

Abstract

APAF1, encoding the protein apoptosis protease activating factor 1 (Apaf-1), has recently been established as a chromosome 12 gene conferring predisposition to major depression in humans. The molecular phenotypes of Apaf-1 variants were determined by in vitro reconstruction of the apoptosome complex in which Apaf-1 activates caspase 9 and thus initiates a cascade of proteolytic events leading to apoptotic destruction of the cell. Cellular phenotypes were measured using a yeast heterologous expression assay in which human Apaf-1 and other proteins necessary to constitute a functional apoptotic pathway were overexpressed. Apaf-1 variants encoded by APAF1 alleles that segregate with major depression in families linked to chromosome 12 shared a common gain-of-function phenotype in both assay systems. In contrast, other Apaf-1 variants showed neutral or loss-of-function phenotypes. The depression-associated alleles thus have a common phenotype that is distinct from that of non-associated variants. This result suggests an etiologic role for enhanced apoptosis in major depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16231040     DOI: 10.1038/sj.mp.4001755

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  13 in total

Review 1.  What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?

Authors:  Boldizsár Czéh; Paul J Lucassen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-08       Impact factor: 5.270

2.  Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms.

Authors:  Lina Chiuccariello; Sylvain Houle; Laura Miler; Robert G Cooke; Pablo M Rusjan; Grazyna Rajkowska; Robert D Levitan; Stephen J Kish; Nathan J Kolla; Xiaoming Ou; Alan A Wilson; Jeffrey H Meyer
Journal:  Neuropsychopharmacology       Date:  2013-10-24       Impact factor: 7.853

3.  Structure of an apoptosome-procaspase-9 CARD complex.

Authors:  Shujun Yuan; Xinchao Yu; Maya Topf; Steven J Ludtke; Xiaodong Wang; Christopher W Akey
Journal:  Structure       Date:  2010-05-12       Impact factor: 5.006

4.  Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.

Authors:  Kwangsik Nho; Vijay K Ramanan; Emrin Horgusluoglu; Sungeun Kim; Mark H Inlow; Shannon L Risacher; Brenna C McDonald; Martin R Farlow; Tatiana M Foroud; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie; Alexander B Niculescu; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls.

Authors:  Zenab Amin; Katarzyna Kanarek; Evgeny Krupitsky; Espen Walderhaug; Risto Ilomäki; Hilary Blumberg; Lawrence H Price; Zubin Bhagwagar; Linda L Carpenter; Audrey R Tyrka; Andres Magnusson; Nils Inge Landrø; Edwin Zvartau; Joel Gelernter; C Neill Epperson; Pirkko Räsänen; Jari Siironen; Jaakko Lappalainen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

6.  An association between Epac-1 gene variants and anxiety and depression in two independent samples.

Authors:  Christel M Middeldorp; Jacqueline M Vink; John M Hettema; Eco J C de Geus; Kenneth S Kendler; Gonneke Willemsen; Michael C Neale; Dorret I Boomsma; Xiangning Chen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

7.  Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.

Authors:  M Julia García-Fuster; Jesús A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  2016-06-03       Impact factor: 4.530

8.  Hippocampus-specific regulation of long non-coding RNA and mRNA expression in germ-free mice.

Authors:  Chanjuan Zhou; Xuechen Rao; Haiyang Wang; Benhua Zeng; Yue Yu; Jianjun Chen; Jiaju Zhong; Xunzhong Qi; Li Zeng; Peng Zheng; Wei Hong; Peng Xie
Journal:  Funct Integr Genomics       Date:  2019-11-01       Impact factor: 3.410

9.  Homocysteine as a potential biochemical marker for depression in elderly stroke survivors.

Authors:  Michaela C Pascoe; Sheila G Crewther; Leeanne M Carey; Kate Noonan; David P Crewther; Thomas Linden
Journal:  Food Nutr Res       Date:  2012-04-11       Impact factor: 3.894

Review 10.  Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.

Authors:  Ronald S Duman
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.